Findings on Using Azilect (Rasagiline) as an Add-On Therapy

A Phase 3 Japanese trial has found that adding Azilect (rasagiline) to levodopa is safe, and over the course of a year improved motor function in those with Parkinson’s disease with off periods. The Journal of Neural Transmission published the results of the study Long-Term Safety and Efficacy of Adjunctive Rasagiline in Levodopa-Treated Japanese Patients with Parkinson’s Disease

Read More:

Add-on Azilect Safe and Effective in Levodopa-treated PD Patients, Phase 3 Trial in Japan Shows